Mamatha Bhat
Has grant
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Optimizing the Long-Term Health of Liver Transplant Recipients using Machine Learning Algorithms
Open Date: 2020-10-01
Close Date: 2022-10-01
Grant: Close
Use of Microbiome-Modifying Medications on Post-Transplant Metabolic Disease
Open Date: 2020-09-01
Close Date: 2021-05-01
Grant: Close
Image-guided Delivery of Lipoprotein-Like Nanoparticles to Safely Treat Hepatocellular Carcinoma
Open Date: 2020-09-01
Close Date: 2022-09-01
Grant: Close
Feasibility of a Home-Based Exercise Program in Lung Transplant Recipients to Improve Metabolic Syndrome
Open Date: 2020-07-01
Close Date: 2021-06-01
Grant: Close
Personalized Prevention of Hepatocellular Carcinoma
Open Date: 2020-06-01
Close Date: 2021-01-01
Articles (11)
Background: Liver transplantation (LT) is frequently lifesaving for people living with primary sclerosing cholangitis (PSC). However, patients are waitlisted for LT according to the model for end-stage liver disease-sodium (MELD-Na) score, which may not accurately reflect the burden of living with PSC. We sought to describe and analyze the clinical trajectory for patients with PSC referred for LT, in a mixed deceased donor/living donor transplant program. Methods: This was a retrospective cohort study from November 2012 to December 2019, including all patients with PSC referred for assessment at the University Health Network Liver Transplant Clinic. Patients who required multiorgan transplant or retransplantation were excluded. Liver symptoms, hepatobiliary malignancy, MELD-Na progression, and death were abstracted from chart review. Competing risk analysis was used for timing of LT, transplant type, and death. Results: Of 172 PSC patients assessed, 84% (n = 144) were listed of whom 74% were transplanted. Mean age was 47.6 years, and 66% were male. Overall mortality was 18.2% at 2 years. During the follow-up, 16% (n = 23) were removed from the waitlist for infection, clinical deterioration, liver-related mortality or new cancer; 3 had clinical improvement. At listing, 82% (n = 118) had a potential living donor (pLD). Patients with pLD had significantly lower waitlist and liver-related waitlist mortality (HR 0.20, p <0.001 and HR 0.17, p <0.001, respectively), and higher rates of transplantation (HR 1.83, p = 0.05). Exception points were granted to 13/172 (7.5%) patients. Conclusions: In a high-volume North American LT center, most patients with PSC assessed for transplant were listed and subsequently transplanted. However, this was a consequence of patients engaging in living donor transplantation. Our findings support the concern from patients with PSC that MELD-Na allocation does not adequately address their needs.
Year:
2023
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Make your next move.
Prepare your application
Review drafts before you send them.